Literature DB >> 10930798

Refined deletion mapping in sporadic breast cancer at chromosomal region 8p12-p21 and association with clinicopathological parameters.

S Seitz1, S Werner, J Fischer, A Nothnagel, P M Schlag, S Scherneck.   

Abstract

We have further refined the loss of heterozygosity (LOH) pattern on the human chromosomal region 8p12-p21 using 15 well characterised microsatellite markers in a panel of 50 breast carcinomas. The allelic loss pattern of these tumours suggests the presence of five commonly deleted regions on 8p12-p21. The most commonly deleted region was located between markers D8S1734 and D81989, spanning a distance of approximately 3 cM and reaching 56% LOH at locus NEFL. LOH at 8p12-p21 was significantly correlated with large tumour size (T>5 cm). Patients with the age at diagnosis of breast cancer between 45 and 55 years showed significantly more LOH than patients older than 55 years or younger than 45 years. No correlation was observed between 8p12-p21 alterations and histological tumour type, grade and the presence of lymph node metastases.

Entities:  

Mesh:

Year:  2000        PMID: 10930798     DOI: 10.1016/s0959-8049(00)00135-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  Common genetic variants in NEFL influence gene expression and neuroblastoma risk.

Authors:  Mario Capasso; Sharon Diskin; Flora Cimmino; Giovanni Acierno; Francesca Totaro; Giuseppe Petrosino; Lucia Pezone; Maura Diamond; Lee McDaniel; Hakon Hakonarson; Achille Iolascon; Marcella Devoto; John M Maris
Journal:  Cancer Res       Date:  2014-10-13       Impact factor: 12.701

2.  8p deletion is strongly linked to poor prognosis in breast cancer.

Authors:  P Lebok; A Mittenzwei; M Kluth; C Özden; B Taskin; K Hussein; K Möller; A Hartmann; A Lebeau; I Witzel; S Mahner; L Wölber; F Jänicke; S Geist; P Paluchowski; C Wilke; U Heilenkötter; R Simon; G Sauter; L Terracciano; R Krech; A von der Assen; V Müller; E Burandt
Journal:  Cancer Biol Ther       Date:  2015-05-11       Impact factor: 4.742

3.  Analysis of DLC-1 expression in human breast cancer.

Authors:  Marlies Plaumann; Susanne Seitz; Renate Frege; Lope Estevez-Schwarz; Siegfried Scherneck
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-21       Impact factor: 4.553

4.  NEFL mRNA expression level is a prognostic factor for early-stage breast cancer patients.

Authors:  Xiao-Qing Li; Lin Li; Chun-Hua Xiao; Yu-Mei Feng
Journal:  PLoS One       Date:  2012-02-02       Impact factor: 3.240

5.  An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer.

Authors:  Min Xu; Ming-Chih J Kao; Juan Nunez-Iglesias; Joseph R Nevins; Mike West; Xianghong Jasmine Zhou
Journal:  BMC Genomics       Date:  2008       Impact factor: 3.969

6.  Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer.

Authors:  J Lai; J Flanagan; W A Phillips; G Chenevix-Trench; J Arnold
Journal:  Br J Cancer       Date:  2003-01-27       Impact factor: 7.640

7.  Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes.

Authors:  Núria Bonifaci; Antoni Berenguer; Javier Díez; Oscar Reina; Ignacio Medina; Joaquín Dopazo; Víctor Moreno; Miguel Angel Pujana
Journal:  BMC Med Genomics       Date:  2008-12-18       Impact factor: 3.063

8.  Association between NEFL Gene Polymorphisms and Neuroblastoma Risk in Chinese Children: A Two-Center Case-Control Study.

Authors:  Qiang Wu; Zhen-Jian Zhuo; Jixiao Zeng; Jiao Zhang; Jinhong Zhu; Yan Zou; Ruizhong Zhang; Tianyou Yang; Deli Zhu; Jing He; Huimin Xia
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.